183 related articles for article (PubMed ID: 38216551)
1. Mutant KRAS-activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to activation-induced cell death.
Zhou C; Li W; Liang Z; Wu X; Cheng S; Peng J; Zeng K; Li W; Lan P; Yang X; Xiong L; Zeng Z; Zheng X; Huang L; Fan W; Liu Z; Xing Y; Kang L; Liu H
Nat Commun; 2024 Jan; 15(1):499. PubMed ID: 38216551
[TBL] [Abstract][Full Text] [Related]
2. Mutant KRAS Drives Immune Evasion by Sensitizing Cytotoxic T-Cells to Activation-Induced Cell Death in Colorectal Cancer.
Liu H; Liang Z; Cheng S; Huang L; Li W; Zhou C; Zheng X; Li S; Zeng Z; Kang L
Adv Sci (Weinh); 2023 Feb; 10(6):e2203757. PubMed ID: 36599679
[TBL] [Abstract][Full Text] [Related]
3. NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death.
Huang D; Chen J; Yang L; Ouyang Q; Li J; Lao L; Zhao J; Liu J; Lu Y; Xing Y; Chen F; Su F; Yao H; Liu Q; Su S; Song E
Nat Immunol; 2018 Oct; 19(10):1112-1125. PubMed ID: 30224822
[TBL] [Abstract][Full Text] [Related]
4. TNFR1 delivers pro-survival signals that are required for limiting TNFR2-dependent activation-induced cell death (AICD) in CD8+ T cells.
Twu YC; Gold MR; Teh HS
Eur J Immunol; 2011 Feb; 41(2):335-44. PubMed ID: 21268004
[TBL] [Abstract][Full Text] [Related]
5. HOTAIR Up-Regulation Activates NF-κB to Induce Immunoescape in Gliomas.
Wang Y; Yi K; Liu X; Tan Y; Jin W; Li Y; Zhou J; Wang H; Kang C
Front Immunol; 2021; 12():785463. PubMed ID: 34887871
[TBL] [Abstract][Full Text] [Related]
6. Targeting the KRAS, p38α, and NF-κB in lung adenocarcinoma cancer cells: The effect of combining RNA interferences with a chemical inhibitor.
Zarredar H; Pashapour S; Farajnia S; Ansarin K; Baradaran B; Ahmadzadeh V; Safari F
J Cell Biochem; 2019 Jun; 120(6):10670-10677. PubMed ID: 30656741
[TBL] [Abstract][Full Text] [Related]
7. Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer.
Nam GH; Kwon M; Jung H; Ko E; Kim SA; Choi Y; Song SJ; Kim S; Lee Y; Kim GB; Han J; Woo J; Cho Y; Jeong C; Park SY; Roberts TM; Cho YB; Kim IS
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34330763
[TBL] [Abstract][Full Text] [Related]
8. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
[TBL] [Abstract][Full Text] [Related]
9. The superior efficacy of anti-PD-1/PD-L1 immunotherapy in KRAS-mutant non-small cell lung cancer that correlates with an inflammatory phenotype and increased immunogenicity.
Liu C; Zheng S; Jin R; Wang X; Wang F; Zang R; Xu H; Lu Z; Huang J; Lei Y; Mao S; Wang Y; Feng X; Sun N; Wang Y; He J
Cancer Lett; 2020 Feb; 470():95-105. PubMed ID: 31644929
[TBL] [Abstract][Full Text] [Related]
10. KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma.
Ling J; Kang Y; Zhao R; Xia Q; Lee DF; Chang Z; Li J; Peng B; Fleming JB; Wang H; Liu J; Lemischka IR; Hung MC; Chiao PJ
Cancer Cell; 2012 Jan; 21(1):105-20. PubMed ID: 22264792
[TBL] [Abstract][Full Text] [Related]
11. Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer.
Zhou Q; Peng Y; Ji F; Chen H; Kang W; Chan LS; Gou H; Lin Y; Huang P; Chen D; Wei Q; Su H; Liang C; Zhang X; Yu J; Wong CC
Nat Commun; 2023 Aug; 14(1):4677. PubMed ID: 37542037
[TBL] [Abstract][Full Text] [Related]
12. XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer.
Kim J; McMillan E; Kim HS; Venkateswaran N; Makkar G; Rodriguez-Canales J; Villalobos P; Neggers JE; Mendiratta S; Wei S; Landesman Y; Senapedis W; Baloglu E; Chow CB; Frink RE; Gao B; Roth M; Minna JD; Daelemans D; Wistuba II; Posner BA; Scaglioni PP; White MA
Nature; 2016 Oct; 538(7623):114-117. PubMed ID: 27680702
[TBL] [Abstract][Full Text] [Related]
13. CircATXN7 contributes to the progression and doxorubicin resistance of breast cancer via modulating miR-149-5p/HOXA11 pathway.
Wang H; Shan S; Wang H; Wang X
Anticancer Drugs; 2022 Jan; 33(1):e700-e710. PubMed ID: 34845164
[TBL] [Abstract][Full Text] [Related]
14. A miR-29b Byproduct Sequence Exhibits Potent Tumor-Suppressive Activities via Inhibition of NF-κB Signaling in
Inoue A; Mizushima T; Wu X; Okuzaki D; Kambara N; Ishikawa S; Wang J; Qian Y; Hirose H; Yokoyama Y; Ikeshima R; Hiraki M; Miyoshi N; Takahashi H; Haraguchi N; Hata T; Matsuda C; Doki Y; Mori M; Yamamoto H
Mol Cancer Ther; 2018 May; 17(5):977-987. PubMed ID: 29545333
[TBL] [Abstract][Full Text] [Related]
15. IKKβ targeting reduces KRAS-induced lung cancer angiogenesis in vitro and in vivo: A potential anti-angiogenic therapeutic target.
Carneiro-Lobo TC; Scalabrini LC; Magalhães LDS; Cardeal LB; Rodrigues FS; Dos Santos EO; Baldwin AS; Levantini E; Giordano RJ; Bassères DS
Lung Cancer; 2019 Apr; 130():169-178. PubMed ID: 30885340
[TBL] [Abstract][Full Text] [Related]
16. NF-κB activity is downregulated by KRAS knockdown in SW620 cells via the RAS-ERK-IκBα pathway.
Lin G; Tang Z; Ye YB; Chen Q
Oncol Rep; 2012 May; 27(5):1527-34. PubMed ID: 22327383
[TBL] [Abstract][Full Text] [Related]
17. Regulation of autophagy, NF-κB signaling, and cell viability by miR-124 in
Mehta AK; Hua K; Whipple W; Nguyen MT; Liu CT; Haybaeck J; Weidhaas J; Settleman J; Singh A
Sci Signal; 2017 Sep; 10(496):. PubMed ID: 28900044
[No Abstract] [Full Text] [Related]
18. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
[TBL] [Abstract][Full Text] [Related]
19. N
Liu Z; Wang T; She Y; Wu K; Gu S; Li L; Dong C; Chen C; Zhou Y
Mol Cancer; 2021 Aug; 20(1):105. PubMed ID: 34416901
[TBL] [Abstract][Full Text] [Related]
20. Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B.
Jeay S; Pianetti S; Kagan HM; Sonenshein GE
Mol Cell Biol; 2003 Apr; 23(7):2251-63. PubMed ID: 12640111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
